Effectiveness of mRNA COVID-19 Monovalent and Bivalent Vaccine Booster Doses Against Omicron Severe Outcomes Among Adults Aged ≥50 Years in Ontario, Canada: A Canadian Immunization Research Network Study

被引：7
|
作者：
Grewal, Ramandip [1 ,2 ,3 ]
Buchan, Sarah A. [1 ,2 ,3 ,4 ]
Nguyen, Lena [4 ]
Nasreen, Sharifa [2 ,4 ]
Austin, Peter C. [4 ,5 ]
Brown, Kevin A. [1 ,2 ,4 ]
Gubbay, Jonathan [1 ,6 ]
Lee, Nelson [2 ,7 ]
Schwartz, Kevin L. [1 ,2 ,4 ]
Tadrous, Mina [8 ]
Wilson, Kumanan [9 ,10 ,11 ]
Wilson, Sarah E. [1 ,2 ,3 ,4 ]
Kwong, Jeffrey C. [1 ,2 ,3 ,4 ,12 ,13 ]
机构：
[1] Publ Hlth Ontario, Toronto, ON, Canada
[2] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
[3] Univ Toronto, Ctr Vaccine Preventable Dis, Toronto, ON, Canada
[4] ICES, Toronto, ON, Canada
[5] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
[6] British Columbia Childrens & Womens Hlth Ctr, Dept Pathol & Lab Med, Vancouver, BC, Canada
[7] Womens Coll Hosp, Inst Hlth Syst Solut & Virtual Care, Toronto, ON, Canada
[8] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada
[9] Univ Ottawa, Dept Med, Ottawa, ON, Canada
[10] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada
[11] Bruyere Res Inst, Ottawa, ON, Canada
[12] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada
[13] Univ Hlth Network, Toronto Western Family Hlth Team, Toronto, ON, Canada
来源：
JOURNAL OF INFECTIOUS DISEASES | 2024年 / 229卷 / 02期
基金：
加拿大健康研究院;
关键词：
bivalent; COVID-19; mRNA; vaccine effectiveness; Omicron;
D O I：
10.1093/infdis/jiad419
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
We estimated the effectiveness of booster doses of monovalent and bivalent mRNA COVID-19 vaccines against Omicron-associated severe outcomes among adults aged >= 50 years in Ontario, Canada. Monovalent and bivalent mRNA COVID-19 booster doses provided similar strong initial protection against severe outcomes. Uncertainty remains around waning of protection from these vaccines. Shortly after bivalent mRNA COVID-19 vaccines were introduced, monovalent and bivalent booster doses provided similar strong initial protection against severe outcomes among Ontario community-dwelling adults aged >= 50 years. Uncertainty remains around waning of protection.
引用
收藏
页码：394 / 397
页数：4
相关论文
共 29 条
  • [1] COVID-19 vaccine effectiveness against severe omicron-related outcomes in children aged 5 to 11 years in Ontario: A Canadian immunization research network (CIRN) study
    Piche-Renaud, Pierre-Philippe
    Drover, Samantha S. M.
    Austin, Peter C.
    Morris, Shaun K.
    Buchan, Sarah A.
    Nasreen, Sharifa
    Schwartz, Kevin L.
    Tadrous, Mina
    Thampi, Nisha
    Wilson, Sarah E.
    Wilson, Kumanan
    Guttmann, Astrid
    Kwong, Jeffrey C.
    VACCINE, 2025, 44
  • [2] Vaccine effectiveness and duration of protection of COVID-19 mRNA vaccines against Delta and Omicron BA.1 symptomatic and severe COVID-19 outcomes in adults aged 50 years and over in France
    Tchuem, Cynthia Raissa Tamandjou
    Auvigne, Vincent
    Vaux, Sophie
    Montagnat, Charline
    Paireau, Juliette
    Besnard, Stephanie Monnier
    Gabet, Amelie
    Benhajkassen, Nabil
    Le Strat, Yann
    Chatelet, Isabelle Parent Du
    Levy-Bruhl, Daniel
    VACCINE, 2023, 41 (13) : 2280 - 2288
  • [3] Effectiveness of first and second COVID-19 mRNA vaccine monovalent booster doses during a period of circulation of Omicron variant sublineages: December 2021-July 2022
    Petrie, Joshua G.
    King, Jennifer P.
    McClure, David L.
    Rolfes, Melissa A.
    Meece, Jennifer K.
    Pattinson, David
    Neumann, Gabriele
    Kawaoka, Yoshihiro
    Belongia, Edward A.
    McLean, Huong Q.
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2023, 17 (03)
  • [4] The Bivalent COVID-19 Booster Immunization after Three Doses of Inactivated Vaccine Augments the Neutralizing Antibody Response against Circulating Omicron Sublineages
    He, Qiaren
    Sun, Shiyu
    Chen, Xi
    Hu, Zhenxiang
    Zhang, Yan
    Peng, Hua
    Fu, Yang-Xin
    Yang, Jiaming
    Chen, Long
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (01)
  • [5] Effectiveness and durability of a second COVID-19 booster against severe outcomes among older people in Norway: a population-based cohort study comparing mono- and bivalent booster doses
    Stecher, Melanie
    Kristoffersen, Anja Brathen
    Lie, Kristian
    Andersen, Svein Rune
    Meijerink, Hinta
    Starrfelt, Jostein
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2023, 52 (06) : 1716 - 1724
  • [6] Bivalent mRNA vaccine effectiveness against COVID-19 among older adults in Japan: a test-negative study from the VENUS study
    Tamada, Yudai
    Takeuchi, Kenji
    Kusama, Taro
    Maeda, Megumi
    Murata, Fumiko
    Osaka, Ken
    Fukuda, Haruhisa
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [7] Bivalent mRNA vaccine effectiveness against COVID-19 among older adults in Japan: a test-negative study from the VENUS study
    Yudai Tamada
    Kenji Takeuchi
    Taro Kusama
    Megumi Maeda
    Fumiko Murata
    Ken Osaka
    Haruhisa Fukuda
    BMC Infectious Diseases, 24
  • [8] Evaluating the Effectiveness of mRNA-1273.815 Against COVID-19 Hospitalization Among Adults Aged ≥ 18 Years in the United States
    Wilson, Amanda
    Rahai, Neloufar
    Beck, Ekkehard
    Beebe, Elisha
    Conroy, Brian
    Esposito, Daina
    Govil, Priya
    Kopel, Hagit
    Lu, Tianyi
    Mansi, James
    Marks, Morgan A.
    Mues, Katherine E.
    Shah, Rohan
    Skornicki, Michelle
    Sun, Tianyu
    Toyip, Astra
    Yousefi, Mitra
    Martin, David
    Araujo, Andre B.
    INFECTIOUS DISEASES AND THERAPY, 2025, 14 (01) : 199 - 216
  • [9] Effectiveness of two and three mRNA COVID-19 vaccine doses against Omicron- and Delta-Related outpatient illness among adults, October 2021-February 2022
    Kim, Sara S.
    Chung, Jessie R.
    Talbot, H. Keipp
    Grijalva, Carlos G.
    Wernli, Karen J.
    Kiniry, Erika
    Martin, Emily T.
    Monto, Arnold S.
    Belongia, Edward A.
    McLean, Huong Q.
    Gaglani, Manjusha
    Mamawala, Mufaddal
    Nowalk, Mary Patricia
    Geffel, Krissy Moehling
    Tartof, Sara Y.
    Florea, Ana
    Lee, Justin S.
    Tenforde, Mark W.
    Patel, Manish M.
    Flannery, Brendan
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2022, 16 (06) : 975 - 985
  • [10] Reported effectiveness of COVID-19 monovalent booster vaccines and hybrid immunity against mild and severe Omicron disease in adults: A systematic review and meta-regression analysis
    Nealon, Joshua
    Mefsin, Yonatan M.
    McMenamin, Martina E.
    Ainslie, Kylie E. C.
    Cowling, Benjamin J.
    VACCINE: X, 2024, 17
123